Literature DB >> 3908321

Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy.

J A O'Hare, J B Ferriss, D Brady, B Twomey, D J O'Sullivan.   

Abstract

The objective of this study was to examine total exchangeable sodium, plasma-blood volume, and the status of the renin-angiotensin system in hypertensive diabetic patients with established nephropathy. We also evaluated hypertensive patients with diabetes who were free of clinically apparent nephropathy or other diabetic complications. Total exchangeable sodium (by 24Na dilution) was expressed as percentage predicted. Subjects were studied as inpatients receiving unrestricted sodium intake and in stable metabolic control. Total exchangeable sodium was 100 +/- 2% in controls (n = 42), higher (p less than 0.01) at 108 +/- 2% in normotensive patients with diabetes (n = 30), and higher still (p less than 0.005) in hypertensive patients with diabetic nephropathy (n = 16) 118 +/- 4% (p less than 0.05 vs normotensive diabetics). The value correlated with blood pressure only in diabetics with nephropathy (r = 0.61, p less than 0.01). Plasma renin activity, and blood and plasma volumes were similar in nephropathic diabetics and controls. Hypertensive patients with maturity-onset (type II) diabetes free of nephropathy (n = 18) were compared with nondiabetic controls (n = 16) and normotensive patients with type II diabetes (n = 18) of similar age. Total exchangeable sodium in the controls was 100 +/- 3%, higher (p less than 0.01) in normotensive diabetics at 109 +/- 2%, but not significantly elevated in hypertensive diabetics at 106 +/- 2%. Again, blood and plasma volumes did not differ among the groups. Plasma renin activity was suppressed (p less than 0.01) to a comparable degree in both normotensive and hypertensive patients with type II diabetes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3908321     DOI: 10.1161/01.hyp.7.6_pt_2.ii43

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

1.  Prevalence of hypertension in type 1 (insulin-dependent) diabetes mellitus.

Authors:  G C Viberti; R Trevisan; R Nosadini
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

Review 2.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

3.  Lack of evidence of hypervolemia in children with insulin-dependent diabetes mellitus.

Authors:  Ann Raes; Sarah Van Aken; Margarita Craen; Raymond Donckerwolcke; Johan Vande Walle
Journal:  Pediatr Nephrol       Date:  2006-11-09       Impact factor: 3.714

Review 4.  ACE inhibitors in the prevention and therapy of diabetic nephropathy. What is their role?

Authors:  C C Kelleher
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

5.  Increased prevalence of salt sensitivity of blood pressure in IDDM with and without microalbuminuria.

Authors:  K Strojek; W Grzeszczak; B Lacka; J Gorska; C K Keller; E Ritz
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

Review 6.  Treatment of hypertension in diabetic patients with nephropathy.

Authors:  R Komers; S Anderson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 7.  Urinary serine proteases and activation of ENaC in kidney--implications for physiological renal salt handling and hypertensive disorders with albuminuria.

Authors:  Per Svenningsen; Henrik Andersen; Lise H Nielsen; Boye L Jensen
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

8.  Insulin resistance is associated with high plasma ouabain-like immunoreactivity concentration in NIDDM.

Authors:  T Wasada; H Kuroki; M Naruse; H Arii; A Maruyama; K Katsumori; S Saito; Y Watanabe; K Naruse; H Demura
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

9.  Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Deckert; J Giese; N J Christensen; L Bent-Hansen; M D Nielsen
Journal:  Diabetologia       Date:  1987-08       Impact factor: 10.122

10.  Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells.

Authors:  P R Standley; F Zhang; J L Ram; M B Zemel; J R Sowers
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.